AbbVie Inc.
Biopharmaceutical company with strong dividend growth track record. Humira franchise and expanding pipeline support consistent dividend increases and attractive yield.
The AbbVie Inc. ABBV dividend offers investors a current yield of 3.60% with 11 consecutive years of dividend payments, making it a compelling choice for income-focused portfolios.
AbbVie Inc. ABBV Dividend Metrics
10-Year Dividend History
Annual Dividend per Share ($)
Investment Highlights
Proven Dividend Track Record
The AbbVie Inc. ABBV dividend has been paid for 11 consecutive years, demonstrating consistent commitment to shareholder returns.
Attractive Dividend Yield
With a current dividend yield of 3.60%, AbbVie Inc. offers a balanced approach to dividend income and potential capital appreciation.
Dividend Sustainability
The payout ratio of 48% suggests excellent dividend coverage with significant room for future growth.
Investment Disclaimer
This information is provided for educational purposes only and does not constitute investment advice, financial advice, trading advice, or any other sort of advice. AbbVie Inc. stock information, dividend metrics, and analysis are provided as-is without any warranty. Always conduct your own research and consult with a qualified financial advisor before making investment decisions. Past dividend performance does not guarantee future results.